Ga-67 citrate imaging in tumors of the genito-urinary tract: report of cooperative study.

Abstract

Whole-body imaging with Ga-67 citrate in 127 tumors of the genito-urinary tract has been evaluated by a cooperative group using a uniform protocol. Primary sites of tumor were not detectable by imaging, except for one bladder and one kidney tumor. Proven and apparent metastases yielded positive scans, however, in 51% of prostatic, 50% of bladder, 72% of kidney, and 53% of testicular neoplasms. In bladder and kidneys metastases, if bone sites are excluded, detection of soft tissue metastases was 61% and 75%, respectively. In embryonal-cell carcinoma of the testicle, 74% of metastatic foci were detected.

• Authors: B J Sauerbrunn, G A Andrews, K F Hübner
• Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 19 Issue 5 Pg. 470-5 (May 1978) ISSN: 0161-5505 [Print] United States
• PMID: 205635 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Gallium Radioisotopes

Topics

• Adenocarcinoma (diagnostic imaging)
• Carcinoma, Papillary (diagnostic imaging)
• Carcinoma, Squamous Cell (diagnostic imaging)
• Carcinoma, Transitional Cell (diagnostic imaging)
• Dysgerminoma (diagnostic imaging)
• Evaluation Studies as Topic
• Female
• Gallium Radioisotopes
• Humans
• Kidney Neoplasms (diagnostic imaging)
• Male
• Neoplasm Metastasis
• Prostatic Neoplasms (diagnostic imaging)
• Radionuclide Imaging
• Teratoma (diagnostic imaging)
• Testicular Neoplasms (diagnostic imaging)
• Urinary Bladder Neoplasms (diagnostic imaging)
• Urogenital Neoplasms (diagnostic imaging)
• Wilms Tumor (diagnostic imaging)